Highlights

  • Genus publishes half-year trading update for H1 FY26 on 16 January 2026.
  • Adjusted profit before tax for H1 FY26 estimated at GBP 50 million, excluding BCA milestone.
  • Formation of Chinese porcine joint venture triggers final milestone payment of GBP 5.6 million.

Genus plc (LSE:GNS) released its unaudited trading update for the six months ended 31 December 2025. The Group expects first-half adjusted profit before tax, excluding the BCA milestone payment, to be approximately GBP 50 million in actual currency. Including the BCA milestone payment, first-half adjusted profit before tax is expected to reach GBP 55.6 million, positioning the company ahead of initial expectations

Chinese Porcine Joint Venture Advances

On 4 September 2025, the company announced the accelerated formation of its porcine joint venture in China. The Group confirmed regulatory approval from China’s State-owned Assets Supervision and Administration Commission (SASAC) in December 2025. This regulatory approval also triggered the final milestone payment from BCA of GBP 5.6 million. The company now expects the formation of the Chinese porcine joint venture and receipt of the milestone cash payment in its fiscal third quarter.

Segment Performance Maintains Momentum
Following the November 2025 AGM trading update, PIC trading continued to be strong while ABS performed as anticipated. Based on these trends, the Board now expects Group FY26 adjusted profit before tax, excluding the BCA milestone payment, to be moderately above the top-end of current market expectations.

Next Steps for Investors
Genus plans to release its interim results for the six-month period from 1 July 2025 to 31 December 2025 on 26 February 2026. This will provide investors with a detailed view of the company’s financial and operational performance for H1 FY26.

At the time of writing, (LSE:GNS) shares are trading at GBX 2860 on 16 January 2026, reflecting an 8.75% increase in day’s return. The stock has also delivered one-year returns of 59.7% as on 16 January 2026.

About Genus

Genus plc is a global animal genetics company improving livestock breeding through biotechnology. Its ABS (dairy and beef) and PIC (pigs) products include semen, embryos, and superior breeding animals. Operating in over 75 countries, Genus combines proprietary animal lines and advanced technology to enhance efficiency and quality. The company is also developing a gene-edited PRRS-resistant pig, pending regulatory approvals. Headquartered in Basingstoke, UK, Genus maintains research labs in Madison, Wisconsin, and operations across six continents.